Condition
Smoke Inhalation Injury
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05886998Phase 3CompletedPrimary
Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
NCT01169155Not ApplicableCompletedPrimary
Critical Smoke Alarm Characteristics to Awaken Children From Stage 4 Sleep
NCT01452191Not ApplicableCompleted
Helping Children's Centres to Enhance Home Safety
NCT03834246UnknownPrimary
Smoke Inhalation Injury in Patients Admitted to Intensive Care
Showing all 4 trials